ATC code V08

ATC codes
V Various
V01 Allergens
V03 All other therapeutic products
V04 Diagnostic agents
V06 General nutrients
V07 All other non-therapeutic products
V08 Contrast media
V09 Diagnostic radiopharmaceuticals
V10 Therapeutic radiopharmaceuticals
V20 Surgical dressings
A B C D G H QI J L M N P R S V (Hover over links to see titles)

ATC code V08 Contrast media is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup V08 is part of the anatomical group V Various.<ref>

ATC/DDD Index 2022

code V08(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV08.<ref>

ATCvet Index 2022

code QV08(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

V08A X-ray contrast media, iodinated

V08AA Water-soluble, nephrotropic, high osmolar X-ray contrast media

V08AA01 Diatrizoic acid

V08AA02 Metrizoic acid

V08AA03 Iodamide

V08AA04 Iotalamic acid

V08AA05 Ioxitalamic acid

V08AA06 Ioglicic acid

V08AA07 Acetrizoic acid

V08AA08 Iocarmic acid

V08AA09 Methiodal

V08AA10 Diodone

V08AB Water-soluble, nephrotropic, low osmolar X-ray contrast media

V08AB01 Metrizamide

V08AB02 Iohexol

V08AB03 Ioxaglic acid

V08AB04 Iopamidol

V08AB05 Iopromide

V08AB06 Iotrolan

V08AB07 Ioversol

V08AB08 Iopentol

V08AB09 Iodixanol

V08AB10 Iomeprol

V08AB11 Iobitridol

V08AB12 Ioxilan

V08AC Water-soluble, hepatotropic X-ray contrast media

V08AC01 Iodoxamic acid

V08AC02 Iotroxic acid

V08AC03 Ioglycamic acid

V08AC04 Adipiodone

V08AC05 Iobenzamic acid

V08AC06 Iopanoic acid

V08AC07 Iocetamic acid

V08AC08 Sodium iopodate

V08AC09 Tyropanoic acid

V08AC10 Calcium iopodate

V08AD Non-watersoluble X-ray contrast media

V08AD01 Ethyl esters of iodised fatty acids

V08AD02 Iopydol

V08AD03 Propyliodone

V08AD04 Iofendylate

V08B X-ray contrast media, non-iodinated

V08BA Barium sulfate containing X-ray contrast media

V08BA01 Barium sulfate with suspending agents

V08BA02 Barium sulfate without suspending agents

V08C Magnetic resonance imaging contrast media

V08CA Paramagnetic contrast media

V08CA01 Gadopentetic acid

V08CA02 Gadoteric acid

V08CA03 Gadodiamide

V08CA04 Gadoteridol

V08CA05 Mangafodipir

V08CA06 Gadoversetamide

V08CA07 Ferric ammonium citrate

V08CA08 Gadobenic acid

V08CA09 Gadobutrol

V08CA10 Gadoxetic acid

V08CA11 Gadofosveset

V08CB Superparamagnetic contrast media

V08CB01 Ferumoxsil

V08CB02 Ferristene

V08CB03 Iron oxide, nanoparticles

V08CX Other magnetic resonance imaging contrast media

V08CX01 Perflubron

V08D Ultrasound contrast media

V08DA Ultrasound contrast media

V08DA01 Microspheres of human albumin

V08DA02 Microparticles of galactose

V08DA03 Perflenapent

V08DA04 Microspheres of phospholipids

V08DA05 Sulfur hexafluoride

V08DA06 Perflubutane polymer microspheres